logo

For the Inventor, By the Inventor

Research Triangle Park, NC, United States of America

Grifols Therapeutics Inc.


USPTO Granted Patents = 26

% Expired Patents = 19.2



Trademarks = 14

Forward Citations = 72

Loading Chart...
Loading Chart...

47 inventors (with patents filed for the assignee):

goldMedal Valery Novokhatny (7 out of 12 patents)

silverMedal Danuta Wronska (4 out of 9 patents)

bronzeMedal Jennifer Audrey Hunt (4 out of 7 patents)

4.  Thomas P Zimmerman (3 out of 14 patents)

5.  James Rebbeor (2 out of 8 patents)

6.  Anthony Klos (2 out of 5 patents)

7.  Jianxin Guo (2 out of 40 patents)

8.  Brett Buno (2 out of 4 patents)

9.  Marco Grebe (2 out of 2 patents)

10.  Deborah Barnette (2 out of 2 patents)

11.  Katherine Schouest (2 out of 2 patents)

12.  Edward Koepf (2 out of 6 patents)

13.  Philip Scuderi, Jr (2 out of 2 patents)

14.  Mark Cornell Manning (1 out of 85 patents)

15.  Charles Miller (1 out of 6 patents)


Core Competencies:
HIV Detection
Immunochromatography
Plasmin Composition
Nucleic Acid Hybridization
Parvovirus B19
IgM Treatment
Lyophilization
Sterile Fluid Pathways
PCR Adjustment
Recombinant Proteins
Amyloid Diseases
Ultrafiltration

26 patents:

1. 10113206 - Methods, compositions, and kits for determining human immunodeficiency virus (HIV) (2018-10-30),
2. 9921229 - Immunochromatography devices, methods, and kits (2018-03-20),
3. 9879246 - Reversibly inactivated acidified plasmin composition (2018-01-30),
4. 9616126 - Composition, method, and kit for alpha-1 proteinase inhibitor (2017-04-11),
5. 9598739 - Human erythrovirus (2017-03-21),
6. 9512493 - Compositions, methods, and kits for nucleic acid hybridization (2016-12-06),
7. 9290820 - Methods for detection of parvovirus B19 (2016-03-22),
8. 9273366 - Methods, compositions, and kits for determining human immunodeficiency virus (HIV) (2016-03-01),
9. 9206410 - Compositions, methods and kits for preparing plasminogen and plasmin prepared therefrom (2015-12-08),
10. 9121857 - Immunochromatography devices, methods and kits (2015-09-01),
11. 8852585 - Method of treatment and prophylaxis of diseases related to amyloid deposition using IgM (2014-10-07),
12. 8840637 - Therapeutic delivery devices, systems, and methods (2014-09-23),
13. 8772461 - Two-stage ultrafiltration/diafiltration (2014-07-08),
14. 8759293 - von Willebrand factor (vWF)-containing preparations, and methods, kits, and uses related thereto (2014-06-24),
15. 8648177 - Lyophilization methods, compositions, and kits (2014-02-11),
Company Overview
Grifols Therapeutics Inc., based in Research Triangle Park, NC, is a global leader in the development and manufacture of plasma-derived medicines. The company specializes in therapies for patients with rare and chronic diseases, focusing on immunology, hematology, and critical care. Grifols is committed to advancing healthcare through innovative research and technology, ensuring the highest quality standards in its products. With a strong emphasis on patient care, Grifols plays a vital role in the biopharmaceutical industry, serving communities worldwide.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

Grifols Therapeutics Inc. USPTO Patent Assignee Logo
26 Patents

#18 in Research Triangle Park, NC

#297 in North Carolina

#12,859 in US

#24,806 in the World

Research Triangle Park, NC (US)
Research Triangle Park, NC, United States of America

Grifols Therapeutics Inc.

Forward Citations = 72

47 inventors:

goldMedal Valery Novokhatny (7 out of 12 patents)

silverMedal Danuta Wronska (4 out of 9 patents)

bronzeMedal Jennifer Audrey Hunt (4 out of 7 patents)

4.  Thomas P Zimmerman (3 out of 14 patents)

5.  James Rebbeor (2 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Grifols Therapeutics Inc.. Retrieved from https://idiyas.com/company/grifols-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…